Lens and refraction · E
Phacoemulsification and intraocular lenses
Cataract surgery as a class of care
Last reviewed: 2026-10-03 · 潘家健醫生
Key points
- Phacoemulsification removes the cloudy lens and places an IOL; optical class is individual — no brand names here.
- Worse pain, sudden vision drop, pus-like discharge or marked redness after surgery: A&E now (rule out endophthalmitis).
- New flashes or many new floaters need same-day dilation; a curtain or sudden blindness: A&E.
- Blur years later is often posterior capsule opacity; YAG is decided after assessment — see the day-of page.
When it is worth discussing surgery
- Reading, driving or TV limited by blur or glare
- Oncoming headlights at night affecting driving safety
- High hyperopia with a narrow angle
- Cataract blocking monitoring of diabetic retinopathy or macular disease
Do you have to wait until it is “ripe”? (a common myth)
In public education, “wait until the cataract is fully ripe / the eye is completely cloudy before surgery” is mostly an older idea, not a general rule in the phaco era. More usual discussion points are whether the cataract already limits reading, driving, night glare, work or fall risk; whether it blocks monitoring of diabetic eye disease or macular disease; and whether a thickening lens adds to narrow-angle risk — decided only after an ophthalmologist examines you. This page does not say “everyone must operate now” or “everyone must wait longer.”
When a lens is hypermature, extremely hard, or the zonules are unstable, surgery can be harder and some complication risks can rise (an education concept, not your personal odds). “Waiting until it is too ripe” is not necessarily safer; conversely, if vision is still adequate and daily life is unhindered, that does not mean surgery must happen immediately. Whether and when to operate is not an advertising timetable.
Before the operation
- Optical biometry of axial length, keratometry and chamber depth; very dense cataracts may need ultrasound axial length
- IOL power calculation — the formula depends on the eye, not one formula for all
- Ocular surface, IOP, endothelium, fundus when visible, glaucoma or macular disease
- Dilation and antiseptic. Whether to pause an anticoagulant is a joint decision — this page does not give a blanket rule
Usual procedure in Hong Kong: phacoemulsification
A consent-style outline, not a clinic’s private protocol. Incision, energy and anaesthesia depend on the nucleus, cornea and general health.
The order of the day, and the diagrams, are on The day of cataract surgery and lens implantation. The lines below keep the consent-style class outline.
- Anaesthesia: usually topical drops, sometimes with intracameral anaesthetic; sedation if needed; general anaesthesia for children or special anatomy
- Dilute iodine on the conjunctiva and lids (an alternative if iodine-allergic); drape and speculum
- Clear-corneal main incision about 2.2–2.7 mm plus a side port; often no suture
- Viscoelastic to protect the endothelium and hold the chamber
- Continuous curvilinear capsulorrhexis — a round window in the anterior capsule
- Hydrodissection to free the nucleus
- Ultrasound emulsifies the nucleus into small fragments and aspirates them
- Femtosecond laser–assisted cataract surgery (FLACS) is another option: laser may assist capsulorrhexis, nucleus fragmentation or incisions, then phaco usually still removes the nucleus. Not everyone needs it. FACT (Day et al., Ophthalmology 2020) was a randomised noninferiority trial: primary vision outcomes versus standard phaco did not show a clinical advantage that would justify writing femto as a “standard upgrade.” FEMCAT (Schweitzer et al., Lancet 2020) was a multicentre randomised trial: superiority was not met, and cost-effectiveness did not support routine universal use. Those are named-trial results — not your personal prognosis, not a clinic or device-brand comparison, and not an advert that femto is “safer / always better.”
- Aspiration of remaining cortex
- A foldable lens is injected into the bag and centred
- Viscoelastic is removed; the wound is hydrated (occasionally one suture)
- Some centres give an intracameral antibiotic. Postoperative steroid, NSAID and/or antibiotic drops are prescribed individually
Uncomplicated cases often take about 15–30 minutes. Most people go home the same day. Vision usually settles over days to weeks — not “surgery’s done and vision’s a perfect hundred.”
Other operations still discussed
- Extracapsular extraction: a larger wound delivering the whole nucleus — dense nuclei, weak zonules or limited equipment; sutures needed
- Lensectomy via the pars plana when combined with vitreous surgery
Optical classes of lens (not a brand pitch)
| Type | Typical features (individual) |
|---|---|
| Monofocal | Clearest at the targeted distance (far, intermediate or near). Other distances usually need glasses. Glare relatively less. |
| Enhanced monofocal | Slightly longer depth of focus. Night optical effects vary by product and pupil; generally less than diffractive multifocals, not a promise of “few halos”. |
| Toric | Corrects regular corneal astigmatism; must sit at the right axis. |
| EDOF | More continuous far-to-intermediate; fine print may still need glasses. |
| Multifocal / trifocal | Tries far, intermediate and near. More glare/halos. Usually unsuitable if there is macular disease or a significant field defect. |
Complication figures from the literature (not any clinic’s success rate)
The ranges below are education-only ballparks; this page’s bibliography (the ESCRS endophthalmitis prophylaxis trial) does not map each row to a percentage. A harder nucleus, trauma, pseudoexfoliation, high myopia, a hypermature lens or combined vitreous surgery raise risk. These figures cannot predict one person, and they are not any clinic’s success rate.
| Event | Note (education; this page’s bibliography does not map each row to a percentage) |
|---|---|
| Posterior capsule rupture / vitreous loss | Uncommon; higher in training; higher with a hard nucleus or incomplete capsulorrhexis |
| Dropped nucleus | Uncommon; may need retinal surgery |
| Suprachoroidal haemorrhage | Very rare but can be severe |
| Endophthalmitis | Uncommon; emergency; this page’s bibliography (ESCRS) emphasises prevention; intracameral antibiotic lowers published rates |
| Clinically significant macular oedema | Post-op macular oedema can occur; higher with diabetes or posterior capsule rupture |
| Retinal detachment after surgery | Uncommon; higher with high myopia, younger age, male sex, or after capsule rupture |
| Endothelial failure / bullous keratopathy | Uncommon; low endothelial counts and high ultrasound energy raise risk |
| Posterior capsule opacification (years) | Not uncommon over years; rates vary by person — see below; not a returning cataract |
Also possible in the first days (most can be managed)
- Transient corneal oedema, foreign-body sensation, photophobia
- A short IOP rise (retained viscoelastic, inflammation or steroid response)
- Wound leak or iris prolapse — uncommon; may need a suture
- Hyphaema, iris trauma, zonular dialysis, a decentred lens
- Refractive surprise: glasses, a contact lens, and rarely lens exchange or corneal laser — individual
- Negative dysphotopsia (a temporal shadow): seen in early literature; most ease over weeks to months
- Toxic anterior segment syndrome: rare sterile inflammation, must be distinguished from infection
Years later: posterior capsule opacification (not a returning cataract)
The implant stays in the original bag. Lens epithelial cells can cloud the posterior capsule over years (PCO, sometimes called an after-cataract). A systematic overview pooled roughly 12% at 1 year, 21% at 3 years, and 28% at 5 years (Schaumberg et al., Ophthalmology 1998; mostly Nd:YAG / discission definitions); a large modern UK registry shows a similar rise with time (RCOphth NOD Report 9, Eye 2023). These are not your personal odds — rates vary with lens, surgery and how PCO is counted. This is not a new lens growing back, and it is not a failed operation.
Blur years after cataract surgery is usually PCO, not a “returning cataract”. Not every blur needs YAG capsulotomy. A doctor must judge whether it affects function and exclude macular, corneal or other causes. The laser is outpatient, with no incision. See the YAG fact sheet. The order of the day is on The day of posterior capsulotomy.
Related public education video (HKOS)
Video source: Hong Kong Ophthalmological Society (HKOS) “Eyes Decoded” YouTube (public education)
This site is not affiliated with, and is not the same organisation as, the Hong Kong Ophthalmological Society (HKOS).
Selected public references (not a full bibliography)
These are the public studies this page draws on. PMID links go to PubMed (US National Library of Medicine) so you can check them. Figures are from those studies — not your prognosis and not a clinic success rate. Links are not a shop.
- ESCRS Endophthalmitis Study Group Prophylaxis of postoperative endophthalmitis following cataract surgery: results of the ESCRS multicenter study and identification of risk factors. J Cataract Refract Surg. 2007;33(6):978-988. PMID 17531690白內障術後眼內炎屬少見但嚴重。數字是多中心試驗,不是任何診所成功率。
- Schaumberg DA, Dana MR, Christen WG, Glynn RJ A systematic overview of the incidence of posterior capsule opacification. Ophthalmology. 1998;105(7):1213-1221. DOI 10.1016/S0161-6420(98)97023-3. PMID 9663224後囊混濁系統回顧匯總(多為需 Nd:YAG/切開定義)。約數不是個人機率;因晶體、手術與定義而異。
- Donachie PHJ, Barnes BL, Olaitan M, Sparrow JM, Buchan JC The Royal College of Ophthalmologists' National Ophthalmology Database study of cataract surgery: Report 9, Risk factors for posterior capsule opacification. Eye (Lond). 2023;37(8):1633-1639. DOI 10.1038/s41433-022-02204-1. PMID 36002508英國 RCOphth NOD 大型登記:後囊混濁風險隨時間上升。公開教育;不作個人預後。
- Day AC, Burr JM, Bennett K, et al. Femtosecond Laser-Assisted Cataract Surgery Versus Phacoemulsification Cataract Surgery (FACT): A Randomized Noninferiority Trial. Ophthalmology. 2020;127(8):1012-1019. DOI 10.1016/j.ophtha.2020.02.028. PMID 32386810飛秒相對傳統超乳的隨機非劣效試驗;主要視力結局未支持「人人升級」。不是個人預後/不是品牌比較。
- Schweitzer C, Brezin A, Cochener B, et al. Femtosecond laser-assisted versus phacoemulsification cataract surgery (FEMCAT): a multicentre participant-masked randomised superiority and cost-effectiveness trial. Lancet. 2020;395(10219):212-224. DOI 10.1016/S0140-6736(19)32481-X. PMID 31954466飛秒優效/成本效益未達常規全面採用門檻。公開試驗;不是診所保證。
This is general medical information, not a diagnosis, and cannot replace an in-person consultation with a registered ophthalmologist, refraction, or a dilated fundus exam. It is not advice to use any medicine or undergo any procedure. Medicines (including off-label use), laser or surgery must be decided by a registered doctor after examination, according to indications and Hong Kong registration. Figures from the literature are published averages, not any clinic’s results. This site does not book, prescribe or refer. Do not change treatment on your own.

